FI935298A0 - Anvaendning av rapamycin prolaekemedel som immunosuppressiva medel - Google Patents

Anvaendning av rapamycin prolaekemedel som immunosuppressiva medel

Info

Publication number
FI935298A0
FI935298A0 FI935298A FI935298A FI935298A0 FI 935298 A0 FI935298 A0 FI 935298A0 FI 935298 A FI935298 A FI 935298A FI 935298 A FI935298 A FI 935298A FI 935298 A0 FI935298 A0 FI 935298A0
Authority
FI
Finland
Prior art keywords
rapamycin
immunosuppressive agents
immunosuppressive
agents
Prior art date
Application number
FI935298A
Other languages
English (en)
Other versions
FI935298A (fi
Inventor
Gary R Schulte
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI935298A publication Critical patent/FI935298A/fi
Publication of FI935298A0 publication Critical patent/FI935298A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI935298A 1991-05-31 1993-11-29 Anvaendning av rapamycin prolaekemedel som immunosuppressiva medel FI935298A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70841291A 1991-05-31 1991-05-31
PCT/US1992/002504 WO1992021341A1 (en) 1991-05-31 1992-04-03 Use of rapamycin prodrugs as immunosuppressant agents

Publications (2)

Publication Number Publication Date
FI935298A FI935298A (fi) 1993-11-29
FI935298A0 true FI935298A0 (fi) 1993-11-29

Family

ID=24845706

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935298A FI935298A0 (fi) 1991-05-31 1993-11-29 Anvaendning av rapamycin prolaekemedel som immunosuppressiva medel

Country Status (8)

Country Link
US (1) US5432183A (fi)
EP (1) EP0586512A1 (fi)
JP (1) JPH06502659A (fi)
CA (1) CA2102116A1 (fi)
FI (1) FI935298A0 (fi)
IE (1) IE921728A1 (fi)
PT (1) PT100556A (fi)
WO (1) WO1992021341A1 (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432183A (en) * 1991-05-31 1995-07-11 Pfizer Inc. Use of rapamycin prodrugs as immunosuppressant agents
ES2258763T3 (es) * 1992-10-13 2006-09-01 Wyeth Carbamatos de rapamicina.
US5258389A (en) * 1992-11-09 1993-11-02 Merck & Co., Inc. O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
US5310903A (en) * 1993-03-05 1994-05-10 Merck & Co., Inc. Imidazolidyl rapamycin derivatives
US5310901A (en) * 1993-03-05 1994-05-10 Merck & Co., Inc. O-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynlheteroarylrapamycin derivatives
US5504091A (en) * 1993-04-23 1996-04-02 American Home Products Corporation Biotin esters of rapamycin
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
US5387680A (en) * 1993-08-10 1995-02-07 American Home Products Corporation C-22 ring stabilized rapamycin derivatives
US5527907A (en) * 1993-11-19 1996-06-18 Abbott Laboratories Macrolide immunomodulators
WO1995014023A1 (en) * 1993-11-19 1995-05-26 Abbott Laboratories Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
US5780462A (en) * 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
US5922730A (en) * 1996-09-09 1999-07-13 American Home Products Corporation Alkylated rapamycin derivatives
WO2001012633A1 (en) * 1999-08-18 2001-02-22 American Home Products Corporation Water soluble sdz-rad esters
EP1313740B1 (en) * 2000-03-29 2005-11-30 ALTANA Pharma AG Prodrugs of imidazopyridine derivatives
SK5072003A3 (en) * 2000-10-25 2003-09-11 Altana Pharma Ag Polysubstituted imidazopyridines as gastric secretion inhibitors
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
JP2005532809A (ja) 2002-07-16 2005-11-04 バイオチカ テクノロジー リミテッド ポリケチド、及び他の天然物の製造
US7160867B2 (en) 2003-05-16 2007-01-09 Isotechnika, Inc. Rapamycin carbohydrate derivatives
US7589233B2 (en) * 2003-07-29 2009-09-15 Signature R&D Holdings, Llc L-Threonine derivatives of high therapeutic index
CA2534342C (en) * 2003-07-29 2016-05-10 V. Ravi Chandran Amino acid prodrugs
US8173840B2 (en) * 2003-07-29 2012-05-08 Signature R&D Holdings, Llc Compounds with high therapeutic index
GB0417852D0 (en) 2004-08-11 2004-09-15 Biotica Tech Ltd Production of polyketides and other natural products
US8021849B2 (en) * 2004-11-05 2011-09-20 Siemens Healthcare Diagnostics Inc. Methods and kits for the determination of sirolimus in a sample
WO2006096325A1 (en) 2005-03-07 2006-09-14 Wyeth Oxepane isomer of 42-o-(2-hydroxy)ethyl-rapamycin
GB0504994D0 (en) 2005-03-11 2005-04-20 Biotica Tech Ltd Novel compounds
AU2006221774A1 (en) 2005-03-11 2006-09-14 Biotica Technology Limited Medical uses of 39-desmethoxyrapamycin and analogues thereof
US7189582B2 (en) * 2005-04-27 2007-03-13 Dade Behring Inc. Compositions and methods for detection of sirolimus
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
AU2006315638B2 (en) 2005-11-11 2013-02-21 V. Ravi Chandran Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements
GB0609963D0 (en) * 2006-05-19 2006-06-28 Biotica Tech Ltd Novel compounds
GB0609962D0 (en) * 2006-05-19 2006-06-28 Biotica Tech Ltd Novel compounds
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
TW200845960A (en) * 2007-04-05 2008-12-01 Wyeth Corp Wortmannin-rapalog conjugate and uses thereof
WO2009131631A1 (en) * 2008-04-14 2009-10-29 Poniard Pharmaceuticals, Inc. Rapamycin analogs as anti-cancer agents
CN102458374A (zh) 2009-05-06 2012-05-16 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
GB201122305D0 (en) 2011-12-23 2012-02-01 Biotica Tech Ltd Novel compound
EP3576736A4 (en) 2017-02-10 2020-08-26 Torcept Therapeutics Inc. RAPAMYCIN ANALOGUE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650803A (en) * 1985-12-06 1987-03-17 University Of Kansas Prodrugs of rapamycin
US5100899A (en) * 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
US5200411A (en) * 1989-06-14 1993-04-06 Sandoz, Ltd. Heteroatoms-containing tricyclic compounds
GB2244991A (en) * 1990-06-11 1991-12-18 Fujisawa Pharmaceutical Co Tricyclo compounds
US5432183A (en) * 1991-05-31 1995-07-11 Pfizer Inc. Use of rapamycin prodrugs as immunosuppressant agents

Also Published As

Publication number Publication date
US5432183A (en) 1995-07-11
FI935298A (fi) 1993-11-29
WO1992021341A1 (en) 1992-12-10
CA2102116A1 (en) 1992-12-01
JPH06502659A (ja) 1994-03-24
PT100556A (pt) 1993-09-30
IE921728A1 (en) 1992-12-02
EP0586512A1 (en) 1994-03-16

Similar Documents

Publication Publication Date Title
FI935298A0 (fi) Anvaendning av rapamycin prolaekemedel som immunosuppressiva medel
FI935309A0 (fi) Vattenloesliga manganpartiklar som medel foer foerstaerkande av magnetisk resonanskontrast
DE69332540T2 (de) Rapamycinderivate
DE69332484D1 (de) Rapamycinderivate
FI921328A (fi) Silyletrar av rapamycin
FI931203A0 (fi) Karboxylsyraestrar av rapamycin
DE69332582D1 (de) Rapamycinderivate
ITBO950462A0 (it) Pittura e relativo uso
FI930722A0 (fi) Foerfarande foer framstaellning av polymerer som innehaoller ammoniumgrupper
DK0680339T3 (da) Ektoparasiticid formulering
FI934764A (fi) Anordning som hindrar krympning av kabelisolering
FI943513A (fi) Kolekystokiniiniantagonisteina käyttökelpoisia 3-fenyyliureidoatsepin-2-oneja ja -bentsatsepin-2-oneja
ITMI932073A0 (it) Derivati di tioalchiltio carbacefalosporina e loro uso come antibiotici
FI930219A (fi) Anvaendning av reaktionsblandningar som gjutbara massor
AT397760B (de) Sitzmöbel
DE59307738D1 (de) Einschlagbarer Bodendübel
KR930025001U (ko) 휴대용 변기
DE9311433U1 (de) Sitzmöbelgarnitur
NO950806D0 (no) Stolkonstruksjon
KR930022879U (ko) 가구의 수평 조절장치
DE9216069U1 (de) Möbelbauelement
DE9307815U1 (de) Sitzmoebel
NO940417D0 (no) Anvendelse av kinolizinderivater som oreksigene midler
KR940000252U (ko) 장식테를 피복한 의자
FI410U1 (fi) Anordning som underlaettar grillning av koettprodukt